2 assets in Atopic Eczema
Therapeutic assets addressing Atopic Eczema, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Broncho-Vaxom Atopic Eczema | OM Pharma SA | P2 | CCC (53) |
Dupilumab Atopic Eczema | Sanofi | P2 | CCC (53) |